A Study to Learn How Safe the Study Treatment BAY2395840 is, How it Affects the Body and How it Moves Into, Through, and Out of the Body if Given in Single and in Repetitive Doses to Japanese Healthy Male Participants
Clinical trial NCT05563454 · COMPLETED
Trial details
- NCT number
- NCT05563454
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2023-02-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.